embecta

News & info about embecta (formerly part of BD) a global #medtech company singularly focused on #DiabetesCare. BD is the manufacturer of advertised products.

[embecta @embecta]

Join our Second Quarter Fiscal Year 2026 earnings call tomorrow at 8:00AM ET. Tune in here: https://t.co/7cp3T2bYHh.

[embecta @embecta]

Today we hosted our Fourth Quarter Fiscal Year 2025 earnings call. You can read the results in our press release here: https://t.co/exQlXvj23y

[embecta @embecta]

Join our fourth quarter fiscal year 2025 earnings call tomorrow at 8:00 a.m. ET. Tune in here: https://t.co/7cp3T2bYHh.

[embecta @embecta]

Today we hosted our Third Quarter Fiscal Year 2025 earnings call. You can read the results in our press release here: https://t.co/a7pBswYccQ

[embecta @embecta]

Join our third quarter fiscal year 2025 earnings call Friday at 8:00AM ET. Tune in here: https://t.co/7cp3T2bYHh.

[embecta @embecta]

We’re excited to host our inaugural Analyst and Investor Day on Thursday, May 22, to showcase our strategic vision and long-range financial plan. Register at https://t.co/X1pMhA10Jd.

[embecta @embecta]

Today we hosted our Second Quarter Fiscal Year 2025 earnings call. You can read the results in our press release here: https://t.co/UfGXAac1jE

[embecta @embecta]

Join our Second Quarter Fiscal Year 2025 earnings call tomorrow at 8:00AM ET. Tune in here: https://t.co/7cp3T2bYHh.

[embecta @embecta]

Find your purpose supporting the #diabetes community by driving innovation in the field. Learn more about our open careers here: https://t.co/WbGs04G2Zv

[embecta @embecta]

Are your patients with #diabetes staying vigilant about #kidneycare? These #WorldKidneyDay reminders can help them keep their kidney health top of mind.

[embecta @embecta]

Today we hosted our First Quarter Fiscal Year 2025 earnings call. You can read the results in our press release here: https://t.co/GQ68CSfJ0x

[embecta @embecta]

Join our First Quarter Fiscal Year 2025 earnings call tomorrow at 8:00AM ET. Tune in here: https://t.co/7cp3T2bYHh.

[embecta @embecta]

Earlier today, our President and CEO Dev Kurdikar presented at #JPM2025.

Miss the live presentation? Check out his remarks here: https://t.co/W1zp3AKGuR

[embecta @embecta]

Come say hello to us tomorrow at #JPM2025! Our President and CEO Dev Kurdikar will be presenting at 7:30 a.m. PT / 10:30 a.m. ET.

Not attending? Listen to the webcast here: https://t.co/W1zp3AKGuR

[embecta @embecta]

Happy New Year 2025!

[embecta @embecta]

We're looking forward to presenting at the 43rd annual J.P. Morgan Healthcare Conference.

Read more about our participation at #JPM2025 in our release: https://t.co/xukSvSUqZZ

[Genpact @Genpact]

We’re proud to partner with @embecta. Our deep expertise in the life sciences & healthcare sectors alongside our capabilities in data and technologies enables embecta’s vision to make a meaningful impact in the healthcare sector. https://t.co/NdkWMXck8w

[DiabetesMine Innovation Project @DData_Diabetes]

Lunch is absorbing and insulin is flowing as #DiabetesMine founder Amy Tenderich gives the opening presentation to kick off #DData2024 Many thanks to the sponsors: @dexcom @EliLillyandCo @myomnipod @embecta and @MannKindCorp

[embecta @embecta]

Join our second quarter fiscal year 2024 earnings call tomorrow at 8:00AM ET. Tune in here: https://t.co/7cp3T2bYHh.

[embecta @embecta]

Today is the day! We're excited to start #ATTD2024 with our Industry Symposium. Join us for insights into exciting #diabetes technology research. Elevate your diabetes care knowledge with us today!